Abstract
Heart transplant rejection is characterized pathologically by myocyte necrosis and apoptosis associated with interstitial mononuclear cell infiltration. Any one of these components can be targeted for noninvasive detection of transplant rejection. During apoptotic cell death, phosphatidylserine, a phospholipid that is normally confined to the inner leaflet of cell membrane bilayer, gets exteriorized. Technetium-99m-labeled annexin-V, an endogenous protein that has high affinity for binding to phosphatidylserine, has been administered intravenously for noninvasive identification of apoptotic cell death. In the present study of 18 cardiac allograft recipients, 13 patients had negative and five had positive myocardial uptake of annexin. These latter five demonstrated at least moderate transplant rejection and caspase-3 staining, suggesting apoptosis in their biopsy specimens. This study reveals the clinical feasibility and safety of annexin-V imaging for noninvasive detection of transplant rejection by targeting cell membrane phospholipid alterations that are commonly associated with the process of apoptosis.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Radionuclide imaging of apoptosis for clinical application
European Journal of Nuclear Medicine and Molecular Imaging Open Access 07 December 2021
-
Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy
Signal Transduction and Targeted Therapy Open Access 16 June 2021
-
Evaluation of 99mTc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis
Arthritis Research & Therapy Open Access 16 August 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Billingham, M.E. et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation (ISHLT). J. Heart Transplant. 9, 587–593 (1990).
Laguens, R.P., Cabeza-Mackert, P.M., San Martino, J., Perrone, S. & Favaloro, S. Identification of programmed cell death (apoptosis) in situ by means of specific labeling of nuclear DNA fragments in heart biopsy samples during acute rejection episodes. J. Heart Lung Transplant. 15, 911–918 (1996).
Szablocs, M.J. et al. Apoptosis and increased expression of inducible nitric oxide synthetase in human allograft rejection. Transplantation 65, 804–812 (1998).
Puig, M. et al. Burden of myocardial damage in cardiac allograft rejection: scintigraphic evidence of myocardial injury and histologic evidence of myocyte necrosis and apoptosis. J. Nucl. Cardiol. 7, 132–139 (2000).
Vermes, I., Haanen, C., Steffens-Nakken, H. & Reutelingsperger, C.P.M. A novel assay for apoptosis flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immuno. Methods 184, 39–51 (1995).
Strauss, H.W., Narula, J., & Blankenberg, F.G. Radioimaging to identify myocardial cell death and probably injury. Lancet 356, 180–181 (2000).
Blankenberg, F.G. et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc. Natl. Acad. Sci. USA 95, 6349–6354 (1998).
Gavrieli, Y., Sherman, Y. & Ben-Sasson, S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119, 493–501 (1992).
Narula, N. et al. Is myofibrillarlytic myocyte an apoptotic myocyte? Mod. Pathol. 13, 52A (2000).
Ohno, M. et al. Apoptotic myocytes in the infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation: analysis by immunogold electromicroscopy combined with in situ nick end labeling. Circulation 98, 1422–1430 (1998).
Kanoh, M. et al. Significance of myocytes with positive DNA end-labeling (TUNEL) in hearts with dilated cardiomyopathy. Circulation 99, 2757–2764 (1999).
Hammond, E.H. et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J. Heart Transplant. 8, 430–443 (1989).
Martin, S.J., Reutelingsperger, C.P.M. & McGahon AJ . Early redistribution of plasma membrane phosphatidylserine in a general feature of apoptosis regardless of the initiating stimulus. J. Exp. Med. 182, 1545–1556 (1995).
Zwaal, R.F. & Schroit, A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89, 1121–1132 (1997).
Fadok, V.A. et al. A receptor for phosphatidylserine specific clearance of apoptotic cells. Nature 405, 85–90 (2000).
Hofstra, L. et al. Visualization of cell death in vivo in patients with acute myocardial infarction. Lancet 356, 209–212 (2000).
Verhoven, B., Schlegel, R.A. & Williamson, P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182, 1597–1601 (1995).
Tait, J.F. & Gibson, D. Measurement of membrane phospholipid asymmetry in normal and sickle-cell erythrocytes by means of annexin V binding. J. Lab. Clin. Med. 123, 741–748 (1994).
Kolodgie, F.D. et al. Tc-99m annexin V imaging for the noninvasive detection of experimental atherosclerotic lesions. Circulation. 102, 404 (2000).
Petrov, A. et al. Sarcolemmal phosphatidylserine expression in ischemic myocardial syndromes can be detected by Tc-99m annexin-V imaging. Circulation 102, 545 (2000).
Gottlieb, R.A., Burleson, K.O., Kloner, R.A., Babior, B.M. & Engler, R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. 94, 1621–1628 (1994).
Kasina, S. et al. Development and biologic evaluation of kit for preformed chelate technetium-99m radiolabeling of an antibody fab fragment using a diamide dimercaptide chelating agent. J. Nucl. Med. 32, 1445–1451 (1991).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Narula, J., Acio, E., Narula, N. et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7, 1347–1352 (2001). https://doi.org/10.1038/nm1201-1347
Issue Date:
DOI: https://doi.org/10.1038/nm1201-1347
This article is cited by
-
Radionuclide imaging of apoptosis for clinical application
European Journal of Nuclear Medicine and Molecular Imaging (2022)
-
Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy
Signal Transduction and Targeted Therapy (2021)
-
Evaluation of cardiac allograft vasculopathy by positron emission tomography
Journal of Nuclear Cardiology (2021)
-
Non-invasive cardiac allograft rejection surveillance: reliability and clinical value for prevention of heart failure
Heart Failure Reviews (2021)
-
A novel BRET based genetic coded biosensor for apoptosis detection at deep tissue level in live animal
Apoptosis (2021)